The Impact of Comorbidities and Sociodemographic Predictors on Pneumococcal Vaccination Coverage in Adults with Coronary Heart Disease

Abstract

Aim: Coronary heart disease (CHD) increases the risk of adverse outcomes from invasive pneumococcal disease. Methods: Using the 2020 and 2021 data from the national health interview survey, we identified adults with CHD. Chi-square analysis and logistic regression were used to examine factors that influence vaccination status. Results: There were 2675 participants aged 41 and above with CHD. Participants were predominantly white people (82.5%) and males (60.1%). The odds of receiving the pneumococcal vaccine increased with stepwise increase in comorbidities from 1 to 2 and from 2 to 3. Among individuals with ≥2 comorbidities, black people were less likely to be vaccinated compared with white people. Conclusion: Pneumococcal vaccine uptake among adults with CHD is determined by cumulative comorbidities and ethnicity.

Keywords::

• comorbidities
• coronary heart disease
• demographic predictors
• ethnicity
• pneumococcal vaccine
• vaccination

Author contributions

Concept, design and data analysis: S-M Allihien, O Kesiena. Drafting of the manuscript: S-M Allihien, S Ibrahim, W Agyeman, O Kesiena. Critical review of the manuscript for important intellectual content: F Markson, W Agyeman, S Fugar. Supervision: O Kesiena.

Acknowledgments

The centers for disease control and prevention for the survey data.

Financial disclosure

The authors have no financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

Competing interests disclosure

The authors have no competing interests or relevant affiliations with any organization or entity with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

Writing disclosure

No writing assistance was utilized in the production of this manuscript.

Ethical conduct of research

An institutional review board evaluation was not needed as this was a publicly available data from the centers for disease control and prevention.